Interventional Cardiology
CK Hui Heart Centre & Royal Alexandra Hospital
Royal Alexandra Hospital & CK Hui Heart Centre
Dr. Debraj Das is an interventional and clinical cardiologist at the Royal Alexandra Hospital and CK Hui Heart Centre. He was born and raised in Edmonton, Alberta, and he attended the University of Alberta, where he received an honorary Bachelor of Medical Sciences degree (2011) and his Doctor of Medicine (2013). He remained at the University of Alberta for his core Internal Medicine and Adult Cardiology residency training (2013-2019). Dr. Das also took on full-time graduate studies during his residency and successfully defended his Master of Science in Translational Medicine (2019). He completed his Royal College of Physicians & Surgeons of Canada certifications in Internal Medicine (2017) and Adult Cardiology (2019) and was accepted into the American College of Cardiology in 2020.
Dr. Das left Edmonton in 2019 to pursue his true passion, interventional cardiology, at the Royal Jubilee Hospital in Victoria, British Columbia. During this two-year clinical fellowship, Dr. Das completed thousands of complex cases and specialized in all aspects of percutaneous coronary intervention (PCI). His main clinical interests include managing stable coronary disease, acute coronary syndromes, left main and bifurcation PCI, coronary physiology, and intravascular imaging.
Outside the demands of his clinical work, Dr. Das has continued to place priority on advancing medical research as well as volunteer work. This ongoing dedication has resulted in more than 40 academic and community service awards at local, provincial, and national levels. He has published numerous academic papers and has presented at several international conferences. Dr. Das was the recipient of Edify Magazine’s Top 40 under 40 award in 2019. As a true Edmontonian, he has his vision set on bolstering the profile of our city through continued clinical research and providing his patients the absolute best care available.
Disclosure(s): Amgen: Speaking Honorarium (Terminated, June 30, 2022); Novartis: Consultancy Board (Ongoing), Speaking Honorarium (Ongoing); Novo Nordisk: Consultancy Board (Terminated, February 28, 2024)
133 - TALES & MYSTERIES FROM THE CATH LAB
Thursday, October 24, 2024
11:00 AM – 12:00 PM PT